FDA label

What is brinzolamide used for?

The FDA-approved uses of brinzolamide, quoted from the Indications and Usage section of its DailyMed label.

Source: DailyMed SPL label file dated 2026-10-23. Publisher page

The FDA label says: “Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.”

Run it in Rivvi

Which 2027 plans near you dropped or restricted brinzolamide?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Brinzolamide, suspension/ drops

Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (ANDA204884). Cross-references to other label sections are left out.

Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.

Source: DailyMed label, set id 37b19837-fcab-4536-abad-6f4f92dfe794, version 9, effective September 28, 2026. NDC 24208-464, one of 4 listings for this product.

Questions

What is brinzolamide used for?

The FDA label says: “Brinzolamide ophthalmic suspension is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.”

What drug class is brinzolamide?

FDA lists brinzolamide in the Carbonic Anhydrase Inhibitor established pharmacologic class.

Does this page cover off-label uses or dosing?

No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.

More on Brinzolamide

Try it on your own data today.

Free to start. Most teams are using it the same day.